Access Resources
1001 - 1025 of 7616 Results
Title
Year
- Parkinson's disease resting tremor severity classification using machine learning with resampling techniques2022RESTRICTEDTitle: Parkinson's disease resting tremor severity classification using machine learning with resampling techniquesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.955464Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.955464/pdfCitation Count: 3
-
RESTRICTEDTitle: Adult-onset KMT2B-related dystoniaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac276Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac276/47057049/fcac276.pdfCitation Count: 2
- Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formation2022RESTRICTEDTitle: Mitoguardin-2–mediated lipid transfer preserves mitochondrial morphology and lipid droplet formationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202207022Best OA location URL: https://rupress.org/jcb/article-pdf/221/12/e202207022/1442103/jcb_202207022.pdfCitation Count: 14
-
RESTRICTEDTitle: Management of psychiatric and cognitive complications in Parkinson’s diseaseJournal Name: BMJPublisher: BMJVol:Issue #:Start Page: e068718End Page: e068718Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/bmj-2021-068718Best OA location URL: https://www.bmj.com/content/bmj/379/bmj-2021-068718.full.pdfCitation Count: 16
- Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting2022RESTRICTEDTitle: Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative LightingJournal Name: LEUKOSPublisher: Informa UK LimitedVol: 19Issue #: 3Start Page: 294End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/15502724.2022.2123816Best OA location URL: https://doi.org/10.1080/15502724.2022.2123816Citation Count: 4
- Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker Studies2022RESTRICTEDTitle: Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker StudiesJournal Name: Journal of Immigrant and Minority HealthPublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 291End Page: 305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10903-022-01411-yCitation Count: 1
- Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort2022RESTRICTEDTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://www.nature.com/articles/s41531-022-00404-w.pdfCitation Count: 5
- Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral Signatures2022RESTRICTEDTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://www.eneuro.org/content/eneuro/9/6/ENEURO.0325-22.2022.full.pdfCitation Count: 5
- Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease2022RESTRICTEDTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 6
-
RESTRICTEDTitle: Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation StudyJournal Name: Journal of Medical Internet ResearchPublisher: JMIR Publications Inc.Vol: 24Issue #: 10Start Page: e40567End Page: e40567Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.2196/40567Best OA location URL: https://www.jmir.org/2022/10/e40567/PDFCitation Count: 3
- Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease2022RESTRICTEDTitle: Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29257Best OA location URL: https://doi.org/10.1002/mds.29257Citation Count: 12
- Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia2022RESTRICTEDTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.846126/pdfCitation Count: 1
-
RESTRICTEDTitle: Cognitive dysfunction 1 year after COVID‐19: evidence from eye trackingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 11Start Page: 1826End Page: 1831Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51675Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51675Citation Count: 6
-
RESTRICTEDTitle: Genetic architecture of Parkinson’s disease subtypes – Review of the literatureJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1023574Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1023574/pdfCitation Count: 17
- Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approach2022RESTRICTEDTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 2
- Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity2022RESTRICTEDTitle: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00388-7Best OA location URL: https://www.nature.com/articles/s41531-022-00388-7.pdfCitation Count: 13
- State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us2022RESTRICTEDTitle: State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell usJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.971007Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.971007/pdfCitation Count: 2
-
RESTRICTEDTitle: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and diseaseJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.1047296Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.1047296/pdfCitation Count: 1
-
RESTRICTEDTitle: QEEG abnormalities in cognitively unimpaired patients with deliriumJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 251End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2022-330010Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/251.full.pdfCitation Count: 2
-
RESTRICTEDTitle: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00400-0Best OA location URL: https://www.nature.com/articles/s41531-022-00400-0.pdfCitation Count: 9
- Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease2022RESTRICTEDTitle: Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1039214Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.1039214/pdfCitation Count: 3
- DBSegment: Fast and robust segmentation of deep brain structures considering domain generalization2022RESTRICTEDTitle: DBSegment: Fast and robust segmentation of deep brain structures considering domain generalizationJournal Name: Human Brain MappingPublisher: WileyVol: 44Issue #: 2Start Page: 762End Page: 778Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.26097Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.26097Citation Count: 4
-
RESTRICTEDTitle: Increased Free Water in the Substantia Nigra in Asymptomatic LRRK2 G2019S Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 138End Page: 142Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29253Citation Count: 3
- Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations2022RESTRICTEDTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://discovery.ucl.ac.uk/10157300/1/Rating%20scales%20for%20medication%20adherence%20in%20Parkinson%20s%20disease.pdfCitation Count: 1
- Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs2022RESTRICTEDTitle: Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugsJournal Name: Frontiers in Bioengineering and BiotechnologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fbioe.2022.1035543Best OA location URL: https://www.frontiersin.org/articles/10.3389/fbioe.2022.1035543/pdfCitation Count: 7